For: | Barreda EG, Avila J. Is tau a suitable therapeutical target in tauopathies? World J Biol Chem 2010; 1(5): 81-84 [PMID: 21540993 DOI: 10.4331/wjbc.v1.i5.81] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v1/i5/81.htm |
Number | Citing Articles |
1 |
S. Mondragón-Rodríguez, G. Perry, F. Peña-Ortega. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. 2017; : 145 doi: 10.1016/B978-0-12-802810-0.00008-8
|
2 |
Lin Li, Zhi-Feng Zhang, Christian Holscher, Chong Gao, Yuan-Hong Jiang, Yue-Ze Liu. (Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains. European Journal of Pharmacology 2012; 674(2-3): 280 doi: 10.1016/j.ejphar.2011.11.005
|
3 |
Cheng Li, Weizhen Liu, Xiaohui Li, Zijuan Zhang, Huaxin Qi, Shijin Liu, Ningning Yan, Ying Xing, Christian Hölscher, Zhiju Wang. The novel GLP‐1/GIP analogue DA5‐CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD. Brain and Behavior 2020; 10(3) doi: 10.1002/brb3.1505
|
4 |
Silvia Bolognin, Julie Blanchard, Xiaochuan Wang, Gustavo Basurto-Islas, Yunn Chyn Tung, Erik Kohlbrenner, Inge Grundke-Iqbal, Khalid Iqbal. An experimental rat model of sporadic Alzheimer’s disease and rescue of cognitive impairment with a neurotrophic peptide. Acta Neuropathologica 2012; 123(1): 133 doi: 10.1007/s00401-011-0908-x
|
5 |
Shaista Chaudhary, Dipak K. Sarkar. Fetal alcohol exposure impairs learning and memory functions and elevates levels of various biochemical markers of Alzheimer's disease in the brain of 12‐month‐old rats. Alcohol: Clinical and Experimental Research 2023; 47(5): 882 doi: 10.1111/acer.15061
|